Relationship between obstructive lung disease and non-alcoholic fatty liver disease in the Korean population: Korea National Health and Nutrition Examination Survey, 2007–2010

References

• NascimbeniFPaisRBellentaniSFrom NAFLD in clinical practice to answers from guidelinesJ Hepatol201359485987123751754
   PubMed Web of Science ®Google Scholar
• GagginiMMorelliMBuzzigoliEDefronzoRABugianesiEGastaldelliANon-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart diseaseNutrients2013551544156023666091
   PubMed Web of Science ®Google Scholar
• TargherGBertoliniLPoliFNonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patientsDiabetes200554123541354616306373
   PubMed Web of Science ®Google Scholar
• MarchesiniGBugianesiEForlaniGNonalcoholic fatty liver, steatohepatitis, and the metabolic syndromeHepatology200337491792312668987
   PubMed Web of Science ®Google Scholar
• FanJGFarrellGCEpidemiology of non-alcoholic fatty liver disease in ChinaJ Hepatol200950120421019014878
   PubMed Web of Science ®Google Scholar
• MurgiaNObstructive lung disease: Occupational exposures smoking and airway inflammation [thesis]GöteborgGöteborgs Universitet2017
   Google Scholar
• DivoMCoteCde TorresJPComorbidities and risk of mortality in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2012186215516122561964
   PubMed Web of Science ®Google Scholar
• FornoEHanYYMuzumdarRHCeledónJCInsulin resistance, metabolic syndrome, and lung function in US adolescents with and without asthmaJ Allergy Clin Immunol2015136230431125748066
   PubMed Web of Science ®Google Scholar
• YehHCPunjabiNMWangNYCross-sectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) studyDiabetes Care200831474174618056886
   PubMed Web of Science ®Google Scholar
• LeoneNCourbonDThomasFLung function impairment and metabolic syndrome: the critical role of abdominal obesityAm J Respir Crit Care Med2009179650951619136371
   PubMed Web of Science ®Google Scholar
• EngströmGHedbladBNilssonPWollmerPBerglundGJanzonLLung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort studyJ Intern Med2003253557458112702035
   PubMed Web of Science ®Google Scholar
• SchroederEBWelchVLCouperDLung function and incident coronary heart disease: the Atherosclerosis Risk in Communities StudyAm J Epidemiol2003158121171118114652302
   PubMed Web of Science ®Google Scholar
• LonardoANascimbeniFPonz de LeonMNonalcoholic fatty liver disease and COPD: is it time to cross the diaphragm?Eur Respir J2017496170054628596428
   PubMed Web of Science ®Google Scholar
• KweonSKimYJangMJData resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES)Int J Epidemiol2014431697724585853
   PubMed Web of Science ®Google Scholar
• KotronenAPeltonenMHakkarainenAPrediction of nonalcoholic fatty liver disease and liver fat using metabolic and genetic factorsGastroenterology2009137386587219524579
   PubMed Web of Science ®Google Scholar
• EckelRHAlbertiKGGrundySMZimmetPZThe metabolic syndromeLancet (London, England)20103759710181183
   PubMed Web of Science ®Google Scholar
• Diagnosis and classification of diabetes mellitusDiabetes care201033Suppl 1S62S6920042775
   PubMedGoogle Scholar
• MartinezCHManninoDMJaimesFAUndiagnosed Obstructive Lung Disease in the United States. Associated Factors and Long-term MortalityAnn Am Thorac Soc201512121788179526524488
   PubMed Web of Science ®Google Scholar
• KoperIGender-Specific Differences in Obstructive Lung DiseasesPneumologie (Stuttgart, Germany)2015696345349
   Google Scholar
• VernonGBaranovaAYounossiZMSystematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adultsAlimentary Pharmacology & Therapeutics201134327428521623852
   PubMed Web of Science ®Google Scholar
• ChalasaniNYounossiZLavineJEThe diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of GastroenterologyGastroenterology201214271592160922656328
   PubMed Web of Science ®Google Scholar
• JeongEHJunDWChoYKRegional prevalence of non-alcoholic fatty liver disease in Seoul and Gyeonggi-do, KoreaClin Mol Hepatol201319326627224133664
   PubMedGoogle Scholar
• ParkHJLeemAYLeeSHComorbidities in obstructive lung disease in Korea: data from the fourth and fifth Korean National Health and Nutrition Examination SurveyInt J Chron Obstruct Pulmon Dis2015101571158226300636
   PubMed Web of Science ®Google Scholar
• ViglinoDJullian-DesayesIMinovesMNonalcoholic fatty liver disease in chronic obstructive pulmonary diseaseEur Respir J2017496160192328596431
   PubMed Web of Science ®Google Scholar
• MapelDWMartonJPPrevalence of renal and hepatobiliary disease, laboratory abnormalities, and potentially toxic medication exposures among persons with COPDInt J Chron Obstruct Pulmon Dis2013812713423515180
   PubMed Web of Science ®Google Scholar
• QinLZhangWYangZImpaired lung function is associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in middle-aged and elderly ChineseBMC Endocrine Disorders20171711828330472
   PubMed Web of Science ®Google Scholar
• JungDHShimJYLeeHRMoonBSParkBJLeeYJRelationship between non-alcoholic fatty liver disease and pulmonary functionInternal medicine journal201242554154622181832
   PubMed Web of Science ®Google Scholar
• MinakataYUedaHAkamatsuKHigh COPD prevalence in patients with liver diseaseInternal Medicine (Tokyo, Japan)2010492426872691
   Web of Science ®Google Scholar
• ByrneCDTargherGNAFLD: a multisystem diseaseJ Hepatol2015621 SupplS47S6425920090
   PubMed Web of Science ®Google Scholar
• MilicSLulicDStimacDNon-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentationsWorld Journal of Gastroenterology201420289330933725071327
   PubMed Web of Science ®Google Scholar
• AndersonDMacneeWTargeted treatment in COPD: a multi-system approach for a multi-system diseaseInt J Chron Obstruct Pulmon Dis2009432133519750192
   PubMedGoogle Scholar
• PolyzosSAMantzorosCSNonalcoholic fatty future diseaseMetabolism20166581007101626805015
   PubMed Web of Science ®Google Scholar
• KugelmasMHillDBVivianBMarsanoLMcClainCJCytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin EHepatology200338241341912883485
   PubMed Web of Science ®Google Scholar
• HuangYSChanCYWuJCPaiCHChaoYLeeSDSerum levels of interleukin-8 in alcoholic liver disease: relationship with disease stage, biochemical parameters and survivalJ Hepatol19962443773848738722
   PubMed Web of Science ®Google Scholar
• SumidaYNikiENaitoYYoshikawaTInvolvement of free radicals and oxidative stress in NAFLD/NASHFree Radical Research2013471186988024004441
   PubMed Web of Science ®Google Scholar
• KeatingsVMCollinsPDScottDMBarnesPJDifferences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthmaAm J Respir Crit Care Med199615325305348564092
   PubMed Web of Science ®Google Scholar
• LiangRZhangWSongYMLevels of leptin and IL-6 in lungs and blood are associated with the severity of chronic obstructive pulmonary disease in patients and rat modelsMol Med Rep2013751470147623525184
   PubMed Web of Science ®Google Scholar
• KirkhamPABarnesPJOxidative stress in COPDChest2013144126627323880677
   PubMed Web of Science ®Google Scholar
• HashimotoETaniaiMTokushigeKCharacteristics and diagnosis of NAFLD/NASHJ Gastroenterol Hepatol201328Suppl 4647024251707
   PubMed Web of Science ®Google Scholar